08.28.26 -- Building A Self-Driving Lab For LNP Development

Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

Therapeutic peptide manufacturing depends on more than synthesis. Discover approaches for verifying raw materials, detecting difficult impurities, and confirming complex sequences with confidence.

Disconnected data slows development and increases risk. See how a structured knowledge management strategy strengthens QbD execution, improves efficiency, and reduces costs.

Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.

Quality is no longer just about compliance. Uncover how a unified, data‑driven quality mindset supports scalable manufacturing, reduces variability, and helps organizations meet expectations.

To ensure the commercial success of cell therapies, developers must adopt innovative manufacturing and QC technologies that reduce COGS while enhancing scalability, quality, and clinical outcomes.

Learn how academic labs can reduce downtime, streamline maintenance, and keep experiments running smoothly through preventive care, remote support, training, and smarter spare parts planning.

Complex biologics require flexible development, advanced analytics, and quality by design. Delve into how collaborative bioprocessing reduces risk and enables efficient scale‑up.

Using advanced biophysical techniques, researchers like Miklós Kellermayer have shed light on the behavior of individual biomolecules, driving breakthroughs in understanding molecular intricacies.

Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production.

Platforms incorporating high throughput in silico screening, in vitro expression, and immunosafety of multi-specific molecules can help mitigate potential developability risks and accelerate timelines.

Accelerate Huntington’s disease research with high-affinity monoclonal antibodies targeting DNA mismatch repair proteins to uncover their role in CAG expansion.

The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs.

Magnetic tweezer experiments often seek to measure changes in the extension or relaxation of a polymer, a functionality useful in exploring how different enzymes manipulate polymer structures.

Lipid nanoparticles (LNPs) carry immense potential as delivery systems. Learn about the development of isocratic and gradient methods for high-throughput separation of lipids used in LNP formulations.

While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability.